Cargando…
Late recurrence of breast cancer is associated with pro-cancerous immune microenvironment in the primary tumor
The fact that 20–40% of all breast cancer (BC) patients develop recurrence when 5 year survival is 90% strongly suggests that late recurrence, i.e. more than 5 years after diagnosis, is the remaining challenge to decrease the absolute number of BC deaths. Better understanding late recurrence is an e...
Autores principales: | Takeshita, Takashi, Yan, Li, Asaoka, Mariko, Rashid, Omar, Takabe, Kazuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6858361/ https://www.ncbi.nlm.nih.gov/pubmed/31729458 http://dx.doi.org/10.1038/s41598-019-53482-x |
Ejemplares similares
-
Biologically Aggressive Phenotype and Anti-cancer Immunity Counterbalance in Breast Cancer with High Mutation Rate
por: Takahashi, Hideo, et al.
Publicado: (2020) -
APOBEC3-Mediated RNA Editing in Breast Cancer is Associated with Heightened Immune Activity and Improved Survival
por: Asaoka, Mariko, et al.
Publicado: (2019) -
Enhanced Thermogenesis in Triple-Negative Breast Cancer Is Associated with Pro-Tumor Immune Microenvironment
por: Gandhi, Shipra, et al.
Publicado: (2021) -
Neoadjuvant Chemotherapy for Breast Cancer: Past, Present, and Future
por: Asaoka, Mariko, et al.
Publicado: (2020) -
High Expression of microRNA-143 is Associated with Favorable Tumor Immune Microenvironment and Better Survival in Estrogen Receptor Positive Breast Cancer
por: Tokumaru, Yoshihisa, et al.
Publicado: (2020)